Evidence map›Paper›PMID 33189054›Full record

ArticleEpilepsy & behavior : E&B2020

Prevalence, severity, and associations of depression in people with epilepsy in Guinea: A single-center study.

Mariame Sylla, Andre C Vogel, Aissatou K Bah, Nana R Tassiou, Souleymane D Barry, Bachir A Djibo, Mohamed L Toure, Sakadi Foksona, Mamady Konaté, Fode A Cisse and 1 more

Abstract read
In one paragraph

Article in Epilepsy & behavior : E&B, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Assessing the prevalence of psychotic symptoms in epileptic patients at a tertiary clinic.The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa · 2023
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mariame SyllaHarvard Medical School, Boston, USA.
Andre C VogelDepartment of Neurology, Massachusetts General Hospital, Boston, USA.
Aissatou K BahIgnace Deen Hospital, Conakry, Guinea.
Nana R TassiouIgnace Deen Hospital, Conakry, Guinea.
Souleymane D BarryIgnace Deen Hospital, Conakry, Guinea.
Bachir A DjiboIgnace Deen Hospital, Conakry, Guinea.
Mohamed L ToureIgnace Deen Hospital, Conakry, Guinea.
Sakadi FoksonaIgnace Deen Hospital, Conakry, Guinea.
Mamady KonatéIgnace Deen Hospital, Conakry, Guinea.
Fode A CisseIgnace Deen Hospital, Conakry, Guinea.
Farrah J MateenHarvard Medical School, Boston, USA; Department of Neurology, Massachusetts General Hospital, Boston, USA. Electronic address: fmateen@mgh.harvard.edu.

Funding

CLINICAL UTILITY OF A SMARTPHONE-BASED EEG SYSTEM FOR PEOPLE WITH EPILEPSY IN BHUTANR21NS098886 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI MATEEN, FARRAH JASMINE · 2017 to 2018
$396k
NINDS NIH HHS R21 NS098886
6 · The paper itself

Abstract

BACKGROUND AND

objectiveDepression has long been recognized as a comorbidity of epilepsy in high-income countries, ranging from 17 to 49% of people with epilepsy (PWE). Of the limited studies from sub-Saharan Africa (SSA), where most people have uncontrolled seizures, an even higher prevalence of depression is reported among PWE at times exceeding 80%. We sought to assess the prevalence and severity of depression and its associated factors among PWE in Guinea, a sub-Saharan West African country where most PWE have poorly controlled seizures.

methodsPeople with epilepsy from the community, age 16 years old and above, were consecutively recruited into a convenience cohort at the Ignace Deen Hospital in the capital city, Conakry, in summer 2018 as part of a larger study characterizing PWE in Guinea. Each participant was evaluated by a team of Guinean physicians and a U.S.-based neurologist to confirm the diagnosis of epilepsy. Inperson interviews were performed to measure demographic, clinical, socioeconomic, and related variables. Depression was measured via the Patient Health Questionniare-9 in the language of the participant's preference with a cutoff of 5 or more points being categorized as depressed. Regression analyses were performed to measure the associations between explanatory variables with the outcome of depression.

resultOf 140 PWE (age range: 16-66 years old; 64 female; 64% taking an antiseizure medication including 28% carbamazepine, 16% phenobarbital, and 14% valproic acid; duration of epilepsy: 11 years; 71% with one or more seizures in the past month; 17% never treated with an antiseizure medication; 90% with loss of consciousness during seizures; 10% without formal education; 31% with university level education; 62% using tap water; 48% with a serious seizure-related injury), the point prevalence of depression was 66% (95% confidence interval [CI]: 58%-74%): 43% of PWE had mild depression, 19% moderate, 4% moderate to severe, and 0.1% severe. In a multivariate analysis, the occurrence of a seizure in the past month (odds ratio: 3.03, 95% CI: 2.63-3.48, p = 0.01) was associated with depression, while gender, self-perceived stigma score, serious injuries, and the number of antiseizure medications taken were not statistically significantly associated (p > 0.05). Twenty-five percent of all participants endorsed thoughts of self-harm or suicidality.

conclusionTwo-thirds of PWE in Guinea had depression in this single-institution convenience cohort. The presence of a seizure in the last month was the factor most associated with depression and is modifiable in many PWE. The high prevalance of depression suggests that screening and addressing depressive symptoms should be incorporated into routine epilepsy care in Guinea.

Indexed as

DepressionEpilepsyAdolescentAdultAgedFemaleGuineaHumansMiddle AgedPrevalenceSeizuresYoung AdultAfricaDepressionEpilepsySeizuresStigmaTreatment

Identifiers

PMID33189054
PMCPMC7736546

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.